多巴反应性肌张力障碍,dopa-responsive dystonia
1)dopa-responsive dystonia多巴反应性肌张力障碍
1.TH gene mutation in Chinese patients with autosomal recessivedopa-responsive dystonia;中国人常染色体隐性遗传性多巴反应性肌张力障碍TH基因突变分析
2.Objective:The clinical data ofdopa-responsive dystonia(DRD) has been reviewed.目的:回顾多巴反应性肌张力障碍(dopa-responsive dystonia,DRD)的临床资料,以加深对该病的认识。
3.Dopa-responsive dystonia(DRD)is a rare hereditary disease of motor disorders,with dystonia or gait abnormalities as its first symptom.多巴反应性肌张力障碍是一种好发于儿童或青少年,以肌张力障碍或步态异常为首发症状的少见的遗传性运动障碍疾病,大部分呈常染色体显性遗传,少数呈常染色体隐性遗传,个别可呈散发性。
英文短句/例句
1.Clinical analysis of 15 cases with dopa-responsive dystonia多巴反应性肌张力障碍15例临床分析
2.Clinical Characteristics Analysis for Dopa-responsive Dystonia;多巴反应性肌张力障碍的临床特点分析
3.Objective To explore the clinical feature and treatment method of the dopa responsive dystonia (DRD).目的探讨多巴反应性肌张力障碍的临床特点及治疗。
4.Objective The clinical features, diagnostic and therapeutic methods in dopa-responsive dystonia (DRD) were studied.目的 探讨多巴反应性肌张力障碍的临床特点、诊断和治疗方法。
5.Objective To study the clinical characteristics of patients with dopa-responsive dystonia (DRD).目的研究多巴反应性肌张力障碍患者的临床特点。
6.Study on tetrahydrobiopterin metabolism and gene mutation for dopa-responsive dystonia-a family report.多巴反应性肌张力障碍一家系四氢生物蝶呤代谢与基因研究
7.Study on the Mutations in GTP Cyclohydrolase Ⅰ Gene in the Patients with Dopa Responsive Dystonia多巴反应性肌张力障碍患者鸟苷酸环化水解酶Ⅰ基因突变研究
8.Objective To attach importance to the nursing of dopa－ responsive dystonia. Methods 7 cases from 5 families were treated and nursed with Dopa－ therapy.笔者通过对来自 5个家庭 7例多巴反应性肌张力障碍患者的护理。
9.The mutations in GTP cyclohydrolase Ⅰ gene in Chinese patients with dopa responsive dystonia多巴反应性肌张力障碍三磷酸鸟苷环化水解酶Ⅰ基因突变检测
10.Study on Clinical Characteristics and Causative Gene of Dopa-responsive Dystonia;多巴反应性肌张力障碍的临床特点及基因学研究
11.Conclusion The clinical manifestations of DRD are various and they are closely correlated with age.结论多巴反应性肌张力障碍临床表现呈多样化,临床表现与年龄密切相关。
12.Methods Systematic study of clinical features, diagnosis and therapeutic effect in 10 patients with DRD was performed and retrospectively analyzed.方法 回顾性分析10例多巴反应性肌张力障碍患者的临床表现、诊断方法和治疗效果。
13.Clinical and Molecular Genetic Study of Dopa-responsive Dystonia;多巴敏感性肌张力障碍临床和分子遗传学研究
14.Molecular genetic study of Han nationality dopa-responsive dystonia in three Chinese families汉族多巴敏感性肌张力障碍三个家系的分子遗传学研究(英文)
15.Secondary Nonresponsiveness to Botulinum Toxin A in the Treatment of Cervical Dystonia肉毒毒素治疗颈部肌张力障碍的继发性无应答
16.ADHD AND BARKLEY?S BEHAVIOR INHIBITORY MODEL注意力缺损多动障碍与巴克利的行为反应抑制模型
17.Curative effect observation of the effect of hydro-acupuncture after muscle function localization on cerebral palsy with lower limb dysmyotonia肌肉功能定位水针注射治疗脑性瘫痪下肢肌张力障碍疗效观察
18.Deep brain stimulation for primary generalized dystonia:2 cases reports脑深部电刺激术治疗原发性全身性肌张力障碍(附2例报告)
相关短句/例句
DRD多巴反应性肌张力障碍
1.Background: Dopa-responsive dystonia (DRD) is an eminently treatable dystonia.背景:多巴反应性肌张力障碍(DRD)是一种有良好治疗效果的肌张力障碍,因此认识该病具有重大的临床意义。
3)Dystonia[英][dis"t?uni?][美][d?s"toni?]肌张力障碍
1.Clinical observation on treatment of cranio-cevical dystonia with botulinum toxin A;A型肉毒毒素治疗头颈部肌张力障碍的临床观察
2.Nursing of the patients with dopa_responsive dystonia;多巴反应性肌张力障碍患者的护理
3.Genetics and clinical features of dystonia;肌张力障碍相关基因及临床特征
4)myodystony肌张力障碍
1.Conclusions The clinical features of paroxysmal autonomic nerve dysfunction after brain injury are paroxysmal autonomic nerve dysfunction combiningmyodystony.全组患者均出现发作性躁动、发热、多汗、呼吸急促、心动过速、血压升高、肌张力障碍、抽搐等症状中的多项表现。
5)dysmyotonia肌张力障碍
1.Local injection of type A botulinus toxin is a novel therapy to treat child spasmdysmyotonia.局部肌内注射A型肉毒毒素治疗儿童痉挛型肌张力障碍是一种新的治疗方法。
6)Focal dystonia局限性肌张力障碍
延伸阅读
扭转性肌张力障碍扭转性肌张力障碍即"扭转痉挛"。
